Fecal Microbiome Signatures May Predict Pancreatic Ductal Adenocarcinoma
A team of investigators examined the potential of fecal and salivary microbiota to serve as diagnostic biomarkers for pancreatic ductal adenocarcinoma.
A team of investigators examined the potential of fecal and salivary microbiota to serve as diagnostic biomarkers for pancreatic ductal adenocarcinoma.
Investigators reviewed current pancreatic cancer screening practices and offered recommendations to overcome challenges associated with improving screening efficacy.